Clinical Trials Search | Clareo Health

Showing 1-1 of 1 trials

A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

NCT07005752

The objective of this clinical trial is to evaluate the efficacy and safety of CnU capsule 750 mg administration in patients with Cholesterol gallstone (radiolucent gallstones)

Cholesterol Cholelithiasis

Myungmoon Pharma. Co. Ltd.484 participantsStarted Jul 2025

Busan, South Korea • Gyeonggi-do, South Korea • Gyeonggi-do, South Korea +3 more locations

Data from ClinicalTrials.govTerms

Filters

Filters

A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).